DIVIDEND ANNOUNCEMENT: Organon & Co (NYSE:OGN) on 05/02/2024 declared a dividend of $0.2800 per share

Organon & Co (NYSE:OGN) on 05/02/2024 declared a dividend of $ 0.2800 per share payable on June 13, 2024 to shareholders of record as of May 13, 2024.

Organon & Co (NYSE:OGN) has paid dividends since 2021, has a current dividend yield of 5.9479556084% and has increased its dividends for 0 successive years.

Organon & Co's market cap is $ 4,813,663,540 and has a PE ratio of 4.72. The stock price closed yesterday at $ 18.83 and has a 52 week low/high of $ 10.84 and $ 24.57.

Organon & Co. is a health care company, focused on improving the health of women throughout their lives. Co. develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Co. has a portfolio of medicines and products across a range of therapeutic areas. Co. sells these products through various channels including drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Co. operates manufacturing facilities located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the U.K.

For more information on Organon & Co click here.